Deep vein thrombosis classification scheme: Difference between revisions

Jump to navigation Jump to search
Line 40: Line 40:


* Risk of fatal is very low (1%).
* Risk of fatal is very low (1%).
* Catheter directed thrombolytic therapy.
* Anticoagulants for period of 3 months.


==References==
==References==

Revision as of 03:33, 8 October 2012

Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Ujjwal Rastogi, MBBS [3]; Kashish Goel, M.D.; Assistant Editor(s)-In-Chief: Justine Cadet

Deep Vein Thrombosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Deep vein thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Approach

Assessment of Clinical Probability and Risk Scores

Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Venography

CT

MRI

Other Imaging Findings

Treatment

Treatment Approach

Medical Therapy

IVC Filter

Invasive Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenario

Upper extremity DVT

Recurrence

Pregnancy

Trials

Landmark Trials

Case Studies

Case #1

Deep vein thrombosis classification scheme On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Deep vein thrombosis classification scheme

CDC on Deep vein thrombosis classification scheme

Deep vein thrombosis classification scheme in the news

Blogs on Deep vein thrombosis classification scheme

Directions to Hospitals Treating Deep vein thrombosis

Risk calculators and risk factors for Deep vein thrombosis classification scheme

Overview

Deep vein thrombosis (DVT) is classified based on the site of occlusion or clot formation. Symptom presentation and complication is largely influenced by location of the embolus.

Classification

Classification based on site of thrombus formation

  • Upper extremity deep vein thrombosis (DVT): DVT of the upper limbs.
  • Lower extremity DVT: DVT of the lower limbs, which is subdivided into two categories:
    • Proximal vein thrombosis.
    • Distal (calf) vein thrombosis.

In studies including inpatients, 80% of DVTs are proximal and distal DVT accounts for only 20% of all DVTs [1] [2] [3], while studies with outpatients report a proportion of distal DVT as high as 60–70% [4] [5].

Proximal vein thrombosis

Proximal vein thrombosis involves the proximal veins, including the popliteal, femoral or iliac vein. Proximal vein thrombosis is responsible for more than 90% of acute pulmonary emboli and is associated with higher mortality. [6] Clinically, proximal vein thrombosis is considered severe, as it is more commonly associated with serious, chronic diseases, such as:

More than 90% of cases of acute pulmonary embolism are due to emboli emanating from the proximal, rather than the distal vein, veins of the lower extremities [6].

Distal vein thrombosis

Distal or calf deep vein thrombosis involves infrapopliteal veins [ie, posterior tibial veins, peroneal veins, anterior tibial veins and muscular calf veins (soleal or gemellar veins)]. It is often associated with transient risk factors[6], such as:

  • Recent surgery.
  • Immobilization.
  • Travel.

Upper extremity DVT

  • It is uncommon and accounts for 4 % of all VTE. [7]
  • Risk of embolizing to PE is less. (10%)
  • Risk of fatal is very low (1%).
  • Catheter directed thrombolytic therapy.
  • Anticoagulants for period of 3 months.

References

  1. Anand SS, Wells PS, Hunt D, Brill-Edwards P, Cook D, Ginsberg JS (1998). "Does this patient have deep vein thrombosis?". JAMA. 279 (14): 1094–9. PMID 9546569. Unknown parameter |month= ignored (help)
  2. Wells PS, Hirsh J, Anderson DR; et al. (1995). "Accuracy of clinical assessment of deep-vein thrombosis". Lancet. 345 (8961): 1326–30. PMID 7752753. Unknown parameter |month= ignored (help)
  3. Cogo A, Lensing AW, Prandoni P, Hirsh J (1993). "Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound". Arch. Intern. Med. 153 (24): 2777–80. PMID 8257253. Unknown parameter |month= ignored (help)
  4. Bressollette L, Nonent M, Oger E; et al. (2001). "Diagnostic accuracy of compression ultrasonography for the detection of asymptomatic deep venous thrombosis in medical patients--the TADEUS project". Thromb. Haemost. 86 (2): 529–33. PMID 11521998. Unknown parameter |month= ignored (help)
  5. Oger E (2000). "Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale". Thromb. Haemost. 83 (5): 657–60. PMID 10823257. Unknown parameter |month= ignored (help)
  6. 6.0 6.1 6.2 Galanaud JP, Sevestre-Pietri MA, Bosson JL, Laroche JP, Righini M, Brisot D, Boge G, van Kien AK, Gattolliat O, Bettarel-Binon C, Gris JC, Genty C, Quere I (2009). "Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study". Thromb. Haemost. 102 (3): 493–500. doi:10.1160/TH09-01-0053. PMID 19718469. Retrieved 2011-12-14. Unknown parameter |month= ignored (help)
  7. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ (2004). "Upper-extremity deep vein thrombosis: a prospective registry of 592 patients". Circulation. 110 (12): 1605–11. doi:10.1161/01.CIR.0000142289.94369.D7. PMID 15353493. Retrieved 2012-10-07. Unknown parameter |month= ignored (help)

Template:WH Template:WS